Cargando...
Altered pathways and colorectal cancer prognosis
The identification of molecular markers with prognostic value in colorectal cancer is a challenging task that is needed to define therapeutic guidelines. Clinical factors are insufficient to identify those patients with stage II at risk of relapse or those patients with stage III at low risk. There...
Guardado en:
Publicado en: | BMC Med |
---|---|
Autores principales: | , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4389340/ https://ncbi.nlm.nih.gov/pubmed/25885526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0307-6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|